Sequences

Sample result

Human insulin's gene

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

1,584 publications in 1,066 families match these filters.

  1. US 4431740-A1984-02-14

    DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes

    The Regents of the University of California

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 11 to 343. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    11 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 70
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    71 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 130
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   131 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 190
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   191 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 250
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   251 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 310
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   311 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 343
    

    333 of 333 identical, no gaps.

  2. WO 9632489-A11996-10-17

    GLUCOSE-INDUCIBLE RECOMBINANT VIRAL VECTOR

    INST NAT SANTE RECH MED (FR)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 11 to 343. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    11 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 70
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    71 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 130
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   131 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 190
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   191 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 250
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   251 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 310
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   311 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 343
    

    333 of 333 identical, no gaps.

  3. US 6087129-A2000-07-11

    Recombinant expression of proteins from secretory cell lines

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 23 to 355. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    23 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 82
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    83 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 142
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   143 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 202
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   203 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 262
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   263 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 322
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   323 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 355
    

    333 of 333 identical, no gaps.

  4. US 6110707-A2000-08-29

    Recombinant expression of proteins from secretory cell lines

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 23 to 355. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    23 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 82
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    83 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 142
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   143 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 202
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   203 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 262
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   263 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 322
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   323 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 355
    

    333 of 333 identical, no gaps.

  5. US 6194176-A2001-02-27

    Recombinant expression of proteins from secretory cell lines

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 23 to 355. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    23 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 82
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    83 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 142
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   143 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 202
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   203 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 262
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   263 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 322
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   323 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 355
    

    333 of 333 identical, no gaps.

  6. WO 0168828-A22001-09-20

    Compositions and methods for regulated protein expression in gut

    Engene, Inc. (CA)

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  7. US 6309878-A2001-10-30

    Glucose-inducible recombinant viral vector

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 11 to 343. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    11 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 70
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    71 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 130
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   131 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 190
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   191 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 250
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   251 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 310
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   311 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 343
    

    333 of 333 identical, no gaps.

  8. WO 0212327-A22002-02-14

    Compositions and methods for the therapy and diagnosis of pancreatic cancer

    CORIXA CORPORATION (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 65 to 397. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    65 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 124
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   125 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 184
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   185 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 244
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   245 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 304
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   305 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 364
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   365 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 397
    

    333 of 333 identical, no gaps.

  9. WO 0228408-A22002-04-11

    Compositions and methods for the transport of biologically active agents across cellular barriers

    ARIZEKE PHARMACEUTICALS, INC. (US)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  10. JP 2002524087-A2002-08-06

    Method for studying protein interactions in vivo

    LOMA LINDA UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
    

    333 of 333 identical, no gaps.

  11. WO 02068579-A22002-09-06

    Kits, such as nucleic acid arrays, comprising a majority of humanexons or transcripts, for detecting expression and other uses thereof

    PE Corporation (NY) (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  12. US 6537806-A2003-03-25

    Compositions and methods for treating diabetes

    University of Washington

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  13. JP 2005521635-A2005-07-21

    REMODELING AND GLYCOCONJUGATION OF PEPTIDES

    Neose Technologies Inc

    Query Match 100.0%Identity 100.0%Family of 14

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 14

    Grouped by a shared priority claim, US 60/334233.

  14. WO 2005084697-A2005-09-15

    THE REGULATORS OF EXPRESSION OF ADIPONECTIN RECEPTORS

    TAKASHI KADOWAKI,TOSHIMASA YAMAUCHI

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  15. Novel herpes simplex viruses

    Crusade Laboratories Limited (GB)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  16. JP 2006503588-A2006-02-02

    MODIFIED TRANSFERRIN FUSION PROTEINS

    BIOREXIS PHARMACEUTICAL CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  17. Expression of Mammalian Proteins in Pseudomonas fluorescens

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
    

    333 of 333 identical, no gaps.

  18. JP 2006522738-A2006-10-05

    ERYTHROPOIETIN: REMODELING AND GLYCOCONJUGATION OF ERYTHROPOIETIN

    Neose Technologies Inc,Shawn DeFrees,David Zopf,Robert Bayer,David Hakes, Xi Chen,Caryne Bowe

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  19. US 7125843-A2006-10-24

    Glycoconjugates including more than one peptide

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  20. EP 1716256-A22006-11-02

    Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

    COMPUGEN LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 311 to 643. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   311 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 370
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   371 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 430
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   431 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 490
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   491 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 550
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   551 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 610
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   611 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 643
    

    333 of 333 identical, no gaps.

  21. US 7157277-A2007-01-02

    Factor VIII remodeling and glycoconjugation of Factor VIII

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  22. US 7173003-A2007-02-06

    Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  23. US 7179617-A2007-02-20

    Factor IX: remolding and glycoconjugation of Factor IX

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  24. US 7226903-A2007-06-05

    Interferon beta: remodeling and glycoconjugation of interferon beta

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  25. JP 2007519402-A2007-07-19

    Expression of Mammalian Proteins in Pseudomonas fluorescens

    Dow Global Technologies Inc

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
    

    333 of 333 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 60/537148.

  26. US 7265084-A2007-09-04

    Glycopegylation methods and proteins/peptides produced by the methods

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  27. US 7265085-A2007-09-04

    Glycoconjugation methods and proteins/peptides produced by the methods

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  28. JP 2007525941-A2007-09-13

    GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS

    Neose Technologies Inc,Shawn DeFrees,David Zopf,Robert Bayer,David Hakes, Xi Chen,Caryne Bowe

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  29. US 7297511-A2007-11-20

    Interferon alpha: remodeling and glycoconjugation of interferon alpha

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  30. US 7341869-A2008-03-11

    Compositions and methods for treating diabetes

    The University of Washington

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  31. WO 2008050870-A2008-05-02

    Organ-specific Genes, Method for Identifying Same and Use Thereof

    TAKEDA PHARMACEUTICAL COMPANY LIMITED

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 36 to 368. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    36 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 95
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    96 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 155
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   156 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 215
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   216 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 275
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   276 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 335
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   336 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 368
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. JP 2008518610-A2008-06-05

    Transcriptome Microarray Technology and Methods of Using the Same

    Arradx Limited

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 51 to 383. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    51 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 110
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   111 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 170
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   171 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 230
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   231 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 290
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   291 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 350
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   351 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 383
    

    333 of 333 identical, no gaps.

  33. US 7399613-A2008-07-15

    Sialic acid nucleotide sugars

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  34. US 7416858-A2008-08-26

    Pharmaceutical compositions of glycoconjugates

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  35. US 7439043-A2008-10-21

    Galactosyl nucleotide sugars

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  36. EP 2042189-A12009-04-01

    Use of proinsulin for the preparation of a neuroprotective pharmaceutical composition, therapeutic composition containing it and applications thereof

    CONSEJO SUPERIOR INVESTIGACION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 64 to 396. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    64 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 123
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   124 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 183
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 243
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   244 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 303
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   304 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 363
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   364 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 396
    

    333 of 333 identical, no gaps.

  37. EP 2042196-A22009-04-01

    Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)

    Neose Technologies, Inc. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  38. EP 2097540-A22009-09-09

    Genemap of the human genes associated with crohn's disease

    GENIZON BIOSCIENCES INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 96 to 428. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    96 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 155
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   156 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 215
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   216 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 275
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   276 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 335
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   336 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 395
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   396 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 428
    

    333 of 333 identical, no gaps.

  39. US 7696163-B22010-04-13

    Erythropoietin: remodeling and glycoconjugation of erythropoietin

    Novo Nordisk A/S

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  40. JP 2010124782-A2010-06-10

    Method of preparing protein using nematodes

    Chubu University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 1410 to 1742. Positions start at 1 and include both ends.

    Query    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1410 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 1469
    
    Query   61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1470 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 1529
    
    Query  121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1530 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 1589
    
    Query  181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1590 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 1649
    
    Query  241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1650 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 1709
    
    Query  301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
               |||||||||||||||||||||||||||||||||
    Hit   1710 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 1742
    

    333 of 333 identical, no gaps.

  41. Biomarkers for insulin sensitizer drug response

    IKFE GmbH (DE)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392
    

    333 of 333 identical, no gaps.

  42. US 7795210-B22010-09-14

    Protein remodeling methods and proteins/peptides produced by the methods

    Novo Nordisk A/S

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  43. US 7842459-B22010-11-30

    Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

    Compugen Ltd.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 311 to 643. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   311 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 370
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   371 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 430
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   431 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 490
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   491 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 550
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   551 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 610
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   611 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 643
    

    333 of 333 identical, no gaps.

  44. EP 2265641-A12010-12-29

    BIOMARKERS

    OTAGO INNOVATION LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392
    

    333 of 333 identical, no gaps.

  45. EP 2279754-A22011-02-02

    Remodelling and glycoconjugation of human growth hormone (hGH)

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  46. EP 2279755-A22011-02-02

    Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF)

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  47. EP 2292271-A22011-03-09

    Remodelling and glycoconjugation of an antibody

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  48. EP 2298354-A22011-03-23

    Remodelling and glycoconjugation of interferon-beta

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  49. EP 2305311-A22011-04-06

    Glycoconjugation of peptides

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  50. EP 2305312-A22011-04-06

    Remodelling and glycoconjugation of follicle-stimulating hormone (FSH)

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.